Home
OE Originals
OE Insights
CME
All Specialties
Arthroplasty
Cannabis
Ev. Based Medicine
Foot & Ankle
General Orthopaedics
Hand & Wrist
Metabolic Disorders
Osteoarthritis
Pediatric Orthopaedics
Peri-Operative
Phys. Therapy & Rehab
Shoulder & Elbow
Spine
Sports Medicine
Trauma
Tumour

Author Interviews

Conference Reports

PeerView

All Videos
(137 Videos)

Education
(9 Videos)
Innovation
(0 Videos)
Leadership
(3 Videos)
OrthoJoe
(16 Videos)
Other
(12 Videos)
Personal Growth
(1 Videos)
Practice
(2 Videos)
Research
(18 Videos)

COVID-19 Resource Center

OE World Tour

OE Perspectives

OE Ideas

OE Recommends

To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Loading...
Search Filters

Date Range

to

Report Types

ALL
RCT
META
ACE Reviews

Condition

Region of the Body

Specialties

See all (18)

Emerging Treatments

OE Recommends Topics

Multimedia

Journal

Conference Series

Evidence Series

We found 4 results matching your search query: "Romosozumab"

Showing 1 - 4 of 4
Read Ace Report

Lower incidence of vertebral fracture with romosozumab vs placebo for osteoporosis

N Engl J Med. 2016 Oct 20;375(16):1532-1543

RCT Metabolic Disorders Osteoporosis Postmenopausal Women Lower Extremity Hip Bone Femur Joint Vertebral Neck Fracture Amgen UCB Pharma Denosumab Placebo Romosozumab Subcutaneous Injection - Hide
Read Ace Report

Romosozumab versus placebo, alendronate, and teriparatide for postmenopausal osteoporosis

Climacteric. 2018 Apr;21(2):189-195

Meta-analysis Metabolic Disorders Osteoporosis Postmenopausal Women Alendronate Teriparatide Placebo Romosozumab - Hide
Read Ace Report

WCO-IOF 2016: Greater BMD increase after 1 year of romosozumab vesus teripratide

RCT Metabolic Disorders Osteoporosis Postmenopausal Women Axial Skeleton Spine Spine Lumbar Lower Extremity Hip Bone Femur Neck Amgen Bisphosphonate Subcutaneous Romosozumab Subcutaneous Teriparatide - Hide
Read Ace Report

Romosozumab has no impact on radiographic or clinical outcomes following hip fracture ORIF

J Bone Joint Surg Am. 2020 ;():. 10.2106/JBJS.19.00790

RCT Trauma Appendicular Lower Extremity Hip Bone Femur Intertrochanteric Fracture Placebo Romosozumab Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceutical - Hide
Showing 1 - 4 of 4